Manufacturing & Analytical Characterization
Sujatha Sonti, Dr
VP, Drug Product Development
GSK
Chester Springs, Pennsylvania
Diane Burgess, Ph.D. (she/her/hers)
Distinguished Professor
University of Connecticut
Storrs, Connecticut
Understand the long acting injectables landscape and patient centric design opportunity.
Recognize the interactions between drug substance design and drug product design.
Share the benefits of applying material sparing platforms and predictive models for sterile product process development and control.
Interactions between stability, manufacturability, and biopharmaceutics as part of robust patient centric drug product design (including devices)
Build biopharmaceutics understanding for long acting injectables using an integrated in-vitro/ in-silico/ in-vivo approach across pre-clinical and clinical